Alnylam Pharmaceuticals, Inc. (ALNY)
400.59
-0.10
(-0.02%)
USD |
NASDAQ |
Dec 26, 16:00
398.02
-2.57
(-0.64%)
Pre-Market: 08:58
Alnylam Pharmaceuticals Long Term Notes Receivable (Quarterly)
Long Term Notes Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Non-current Note Receivables Definition
Non-current Note Receivables are the written obligations the creditors receive from the debtors in exchange for funds that are not due within the next twelve months. It is part of a company’s long term assets.
Long Term Notes Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Long Term Notes Receivable (Quarterly) Benchmarks
| Biogen, Inc. | -- |
| Insmed, Inc. | -- |
| Pfizer Inc. | -- |
| Glaukos Corp. | -- |
| BridgeBio Pharma, Inc. | -- |